Document ID: chunk:federal_register_of_legislation:F2024L01327:front:0:p4
Version: federal_register_of_legislation:F2024L01327
Segment Type: other
Provision Reference: 
Character Range: 9166–12094

onset;
14.       having psoriasis at the time of clinical onset;
15.       having rheumatoid arthritis at the time of clinical onset;
16.       having sarcoidosis at the time of clinical onset;
17.       having chronic osteomyelitis with a sinus tract draining to the affected skin site at least 2 years before clinical onset;
Note: sinus tract is defined in the Schedule 1 - Dictionary.
 1.       having non-Hodgkin lymphoma before clinical onset;
 2.       having mature B-cell lymphoid leukaemia and small lymphocytic lymphoma before clinical onset;
Note: Mature B-cell lymphoid leukaemia and small lymphocytic lymphoma is also known as chronic lymphocytic leukaemia/small cell lymphoma.
 1.       having phimosis for a continuous period of at least 2 years before clinical onset of squamous cell carcinoma of the glans penis or prepuce of the penis;
Note: phimosis is defined in the Schedule 1 - Dictionary.
 1.       having a scar at the affected site at least 5 years before clinical onset;
 2.       having ulceration at the affected site for a cumulative period of at least 6 months, at least 5 years before clinical onset;
 3.       having lichen sclerosus at the affected site, at least 5 years before clinical onset of squamous cell carcinoma of the penis, vulva or perianal skin;
 4.       having hidradenitis suppurativa at the affected site, at least 5 years before clinical onset of squamous cell carcinoma of the skin;
Note: hidradenitis suppurativa is defined in the Schedule 1 - Dictionary.
 1.       having chronic lymphoedema at the affected site, at least 5 years before clinical onset of squamous cell carcinoma of the skin;
 2.       smoking at least 15 cigarettes per day for at least 5 years, or the equivalent thereof in other tobacco products, at least 5 years before clinical onset of squamous cell carcinoma of the skin, and where smoking has ceased, clinical onset occurred within 20 years of cessation;
Note: One gram of tobacco is considered to be equivalent to one cigarette.
 1.       being exposed to arsenic as detailed below, at least 10 years before clinical onset;
         1.           consuming arsenic containing compounds (for example, Fowler's solution) for a cumulative period of at least 3 months; or
         2.           consuming drinking water with an average arsenic concentration of at least 50 micrograms per litre for a cumulative period of at least 2 years; or
         3.           inhaling, ingesting or having cutaneous contact with a pesticide containing arsenic, or arsenic in copper smelting operations, for a cumulative period of at least 1,000 hours; or
         4.           having clinical evidence of chronic arsenic toxicity.
 2.       having cutaneous contact at the affected site with coal-tar distillate, for a cumulative period of at least 1,500 hours, at least 5 years before clinical onset;
 3.       having cutaneous contact at the affected site with one